Ledidi AS
Ledidi AS is a Norwegian SaaS company providing an end-to-end cloud platform for clinical research that combines study design, data capture, statistical analysis, and privacy-preserving collaboration for hospitals, pharma, and medtech organisations across Europe and beyond.
- Company typePrivate
- Founded2016
- HeadquartersOslo, Norway
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Ledidi AS does
Ledidi AS is a Norwegian private limited company founded in 2016 and headquartered at Gaustadalléen 21 in Oslo Science Park (Forskningsparken). It provides Ledidi Core, a cloud-native SaaS platform that consolidates clinical study design, structured data capture, statistical analysis, and multi-centre collaboration into a single workspace for healthcare and life science organisations. Target customers include NHS Trusts and academic medical centres, pharmaceutical and biotech companies, medtech and diagnostics firms (e.g., CMR Surgical, Sensocure), and contract research organisations — addressing pain points around fragmented spreadsheet-based registries, slow legacy EDC deployments, and the inability to collaborate on sensitive patient data across institutions while maintaining GDPR/HIPAA compliance. Named deployments include 21 NHS Trusts across the UK (CONCISE study), Norwegian university hospitals (Oslo University Hospital, St. Olavs), the Norwegian Myeloma Registry (~1,000 patients since 2021), the CMR Surgical Versius registry (8,000+ cases), and Pfizer UK-funded breast cancer audits at NHS sites.
The platform is built on AWS infrastructure and is differentiated by Confidential Computing using hardware-based Trusted Execution Environments (AWS Nitro TEEs), which encrypts data in use — not only at rest and in transit — enabling collaborators to run full statistical analyses without any access to the underlying raw patient data. All infrastructure runs on CISPE Code of Conduct-compliant AWS services, allowing data residency entirely within the EEA. Product modules include Ledidi Core (study design, capture, built-in analytics), Ledidi Admin (governance and audit controls for enterprise deployments), and Ledidi Trials (GCP/FDA 21 CFR Part 11-compliant EDC for regulated clinical trials). The platform holds ISO 27001, SOC 2 Type II, HIPAA, NHS DSPT, Cyber Essentials, and CISPE compliance certifications, and is recognised as a Sample Vendor in the Gartner Hype Cycle for Healthcare Data, Analytics, and AI in both 2023 and 2024. Built-in analytics span descriptive statistics, Kaplan-Meier survival, logistic/linear regression, correlation analysis, and R integration, with R integration for advanced statistics and an API for external software interoperability.
Ledidi monetises primarily through SaaS subscriptions with a hybrid fixed/usage-based pricing model: a one-time €3,000 go-live fee, a €100/month baseline, plus €0.025/patient/month and €25.08/site/month variable costs, with a 30% introductory discount available. Enterprise agreements add custom onboarding, scientific support, and premium support at additional cost, and multi-year contracts are typical for larger customers. GTM is hybrid: a product-led self-serve motion (30-day trial at app.ledidi.no) combined with enterprise field sales, supported by strategic distribution partnerships — Pfizer UK funds NHS breast cancer subscriptions via a 'breast clinical audit toolkit' grant, CMR Surgical distributes the platform to Versius hospitals across EMEA/Asia/Latin America, and the company holds a direct public procurement contract with the South-Eastern Regional Health Authority of Norway (Helse Sør-Øst). The company is also listed on the UK Government Digital Marketplace and holds NHS DSPT certification for UK public sector procurement. Leadership is medically credentialed (CEO Einar Martin Aandahl, MD/PhD; CSO Ivar Sjaastad, MD), and the company is privately held with no disclosed venture funding rounds — suggesting founder-financed or capital-efficient bootstrapped growth.
Ledidi AS firmographics
Firmographics- Name
- Ledidi AS
- Legal name
- Ledidi AS
- Website
- https://ledidi.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Ledidi AS is a Norwegian SaaS company providing an end-to-end cloud platform for clinical research that combines study design, data capture, statistical analysis, and privacy-preserving collaboration for hospitals, pharma, and medtech organisations across Europe and beyond.
- Ownership category
- akta.pro rank
Where Ledidi AS is headquartered
LocationHeadquarters
- HQ city
- Oslo
- HQ country
- Norway
- HQ region
- Europe
Offices1 record
Markets served
Ledidi AS business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Infrastructure, Personnel, Marketing or Sales, Operations, Others
Revenue model
- SaaS Subscription — Core Platform: Subscription-based access to Ledidi Core platform. Pricing includes a go-live cost (€3,000 one-time), monthly baseline fee (€100), per-patient variable costs (€0.025/patient/month), and per-site costs (€25.08/site/month). Additional features (monitoring, randomisation, ePROM, eConsent, eTMF) increase per-patient costs. Custom onboarding, educational programs, and scientific support available at additional cost. Subscription tiers differentiated by features and scale.
- Subscription Plans (License Types): Ledidi offers different subscription plans/license types with varying access to platform features. Access to Services depends on the active subscription related to the user account. Both individual user accounts and enterprise/organisation-level agreements are supported.
- Professional Services & Custom Onboarding: Customised onboarding, educational programs, scientific support, and possibly custom development or integration services are available at additional cost beyond the base subscription. Technical support is included at no extra charge; premium support is separately purchasable.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Go-live Cost — One-time platform setup fee |
| Subscription | Monthly | Monthly Baseline Fee — Fixed monthly platform access fee |
| Usage-based | Monthly | Per-Patient Variable Cost — Scales with study size |
| Unit Pricing | Monthly | Per-Site Variable Cost — Scales with number of study sites |
| Subscription | Monthly | Add-on Clinical Trial Modules — Feature upgrades for regulated trials |
| Subscription | Annual | Introductory Discount — New customer offer |
| Subscription | Multi-year contract | Enterprise Agreements — Custom multi-seat/organisation accounts |
Go-to-market motion3 records
Distribution channels6 records
Marketing channels12 records
Ledidi AS product offering
Product offeringCore offering
Ledidi AS provides Ledidi Core, a cloud-native SaaS platform that combines study design, structured data capture, built-in statistical analysis, and multi-centre collaboration for clinical research. The platform supports clinical audits, registries, feasibility studies, post-market surveillance, real-world evidence generation, and GCP/FDA 21 CFR Part 11-compliant clinical trials via the Ledidi Trials add-on. It is offered on a subscription basis to hospitals, NHS Trusts, pharmaceutical and biotech companies, medtech firms, and CROs, with usage-based pricing per patient and per site.
Product overview
Ledidi AS offers Ledidi Core as a unified SaaS platform combining data capture, statistical analysis and collaboration in one secure cloud-based environment. The platform portfolio consists of Ledidi Core (the main platform for clinical audits, registries, and research projects), Ledidi Admin (governance and compliance module for enterprise oversight), and Ledidi Trials (clinical trials module for EDC and GxP compliance). The platform supports the full evidence lifecycle from feasibility studies and registries through clinical trials and post-market surveillance to real-world evidence generation.
Differentiator
Problem solved
Functional benefit
Products and services
- Ledidi Core All-in-one cloud-native platform for clinical audits, registries, and research projects. Provides drag-and-drop study design, structured data capture forms, real-time cross-institution collaboration, built-in statistical analysis and data visualisation, and privacy-preserving multi-centre data sharing for healthcare and life-science professionals, teams, and organisations.
- Ledidi Admin Governance and compliance add-on module providing enterprise-grade administrative controls for organisations, including centralised oversight of user activity, secure management of project access, audit trails, and governance policy enforcement across teams and large-scale regulated deployments.
- Ledidi Trials Clinical trials EDC module offering GCP and FDA 21 CFR Part 11-compliant study setup, electronic data capture, and modular features including monitoring, advanced randomisation, ePROM/eCOA, eConsent, and eTMF. Designed for research teams rather than programmers to launch compliant, cost-effective clinical trials faster than legacy EDC.
Quantifiable outcome
- COVID-19 Omicron/Delta variant study established in 2 weeks with 52 Omicron + 18 Delta patients + 14 controls from Norway and South Africa
- +4 more outcomes
Companies that use Ledidi AS
Customer profileNamed customers17 records
Segments4 records
Ideal customer profiles4 records
Ledidi AS technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability3 records
Feature8 records
Ledidi AS partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered minor, core and flagship.
- SEHTA (South East Health Technologies Alliance)minorLedidi announced membership with SEHTA to strengthen UK presence in health innovation. SEHTA is the UK's largest health technology network supporting SMEs and the adoption of innovation in the NHS. Membership provides networking, marketing, and partnership opportunities within the UK healthcare technology ecosystem.
- BionowminorLedidi announced membership with Bionow to strengthen UK presence in health innovation. Bionow supports biomedical and life science companies in the North of England and provides networking and partnership opportunities.
- Leeds Teaching Hospitals NHS Trust (Innovation Pop Up)corePartnership with Leeds Teaching Hospitals NHS Trust through their Innovation Pop Up programme evaluates Ledidi Core's role in optimising clinical data management. Focused on assessing efficiency of audits and research activities, promoting collaboration across specialties, and supporting improved patient outcomes. Acts as both a customer and a market entry/innovation partner in the UK.
- NordicRWEcoreLedidi and NordicRWE partnered to advance hybrid real-world evidence (RWE) studies and pragmatic trials across the Nordic region. NordicRWE contributes expertise in Nordic health registry data and RWE methodology, while Ledidi provides the collaborative data capture and analysis platform. The partnership aims to enable multi-country RWE studies that combine clinical registry data with pragmatic trial designs.
- Franklyn HealthminorLedidi partnered with Franklyn Health, described as serving companies the industry overlooks. The partnership aims to expand access to Ledidi's platform for underserved segments within the pharmaceutical and healthcare ecosystem.
- beetrootminorLedidi and beetroot partnered to streamline data for cancer and autoimmune care. beetroot provides health data integration and analytics services that complement Ledidi's registry and EDC capabilities.
- Leeds Teaching Hospitals NHS TrustcoreLedidi partnered with Leeds Teaching Hospitals NHS Trust for a clinical service evaluation of Ledidi Core. The partnership includes participation in the NHS Innovation Pop Up programme to assess Ledidi's role in optimising clinical data management, enhancing audit efficiency, promoting cross-specialty collaboration, and supporting improved patient outcomes. Ledidi also worked with Dr John Goodden on SDR surgery database and Dr Olubukola Ayodele on breast cancer clinical trials.
- South-Eastern Regional Health Authority of Norway (Helse Sør-Øst)flagshipLedidi was awarded a contract by the South-Eastern Regional Health Authority of Norway (Helse Sør-Øst), one of Norway's four regional health authorities. This is a significant public sector contract enabling Ledidi Core to be used across the region's hospitals and healthcare institutions.
- CMR SurgicalflagshipCMR Surgical (Cambridge, UK), manufacturer of the Versius surgical robotic system, entered a strategic collaboration with Ledidi in November 2023. CMR uses Ledidi Core as the registry platform for Versius hospitals across Europe, Middle East, Asia, and Latin America. The partnership covers the existing clinical registry (8,000+ surgical cases) and joint development of preclinical and clinical research capabilities as Versius expands into new surgical procedures. Ledidi provides multi-centre data capture, real-time analytics, and collaborative features for CMR's hospital network.
- Medicon Valley Alliance / Oslo Cancer ClusterminorLedidi joined Medicon Valley Alliance (strategic life science cluster spanning Denmark and Sweden) and Oslo Cancer Cluster (Norwegian oncology cluster). Membership provides access to the oncology and life science ecosystem, facilitating partnerships with hospitals, research institutions, and companies across Scandinavia.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
Ledidi AS competitors and assessment
Company assessmentMarket position
Weaknesses4 records
Competitive moat6 records
Customer concentration
Ledidi AS social profiles
Digital presenceLedidi AS compliance and trust
Trust signalCompliance9 records
Ledidi AS financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ledidi AS leadership team
Management profileNumber of profiles
Profiles6 records
Ledidi AS funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ledidi AS M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ledidi AS
What does Ledidi AS do?
Ledidi AS provides Ledidi Core, a cloud-native SaaS platform that combines study design, structured data capture, built-in statistical analysis, and multi-centre collaboration for clinical research. The platform supports clinical audits, registries, feasibility studies, post-market surveillance, real-world evidence generation, and GCP/FDA 21 CFR Part 11-compliant clinical trials via the Ledidi Trials add-on. It is offered on a subscription basis to hospitals, NHS Trusts, pharmaceutical and biotech companies, medtech firms, and CROs, with usage-based pricing per patient and per site.
Is Ledidi AS a public or private company?
Ledidi AS is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Ledidi AS founded?
Ledidi AS was founded in 2016. It employs 11 to 50 people.
Where is Ledidi AS based?
Ledidi AS is headquartered in Oslo, Norway, in the Europe region.
How does Ledidi AS make money?
Three revenue lines are on record. SaaS Subscription — Core Platform is the primary driver. The others are subscription Plans (License Types) and professional Services & Custom Onboarding.
Does Ledidi AS have an API?
Yes. Ledidi Core provides API integration capabilities enabling seamless integration with other software. The platform offers built-in API functionality for data import and integration with external systems. Users can also integrate with the R software environment for advanced statistical analysis.